ClinicalTrials.govpublic full text
The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma
esophageal squamous cell carcinoma (escc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 230396
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.